Document is current

Any future updates will be listed below

Design issues with lutetium-177 PSMA-617 registration studies that bias the outcome of the experimental arm reflect an increasing misalignment of contemporary oncology trials with true patient benefit

Crossref DOI link: https://doi.org/10.1038/s44276-024-00065-7

Published Online: 2024-06-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark